A prospective cohort study of neoadjuvant chemotherapy using carboplatin and dose dense paclitaxel for locally advanced cervical cancer
Not Applicable
Recruiting
- Conditions
- Cervical cancer
- Registration Number
- JPRN-UMIN000031670
- Lead Sponsor
- Hyogo Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with previous radiation therapy. 2. Any active double cancers. 3. Patients with any serious complications. 4. Patients with hypersensitivity to castor ail. 5. Patients with hypersensitivity to alcohol. 6. Carrier of HBV or HCV. 7. Patients with active infection which needs antibiotics. 8. Patients with interstitial pneumonia. 9. Pregnant woman. 10. Patients regard to be inadequate for entering this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 2-year progression free survival rate
- Secondary Outcome Measures
Name Time Method Response rate Pathological complete response rate 2-year overall survival Toxicity Site of recurrence Completion rate of neoadjuvant chemotherapy Pathological mapping of residual tumor Imaging findings of residual tumor